Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | KO-2806 |
Trade Name | |
Synonyms | KO 2806|KO2806 |
Drug Descriptions |
KO-2806 is a farnesyltransferase inhibitor, which may inhibit the Mtor pathway, leading to cell cycle arrest and inhibition of cell growth (Mol Cancer Ther (2023) 22 (12_Supplement): B024). |
DrugClasses | Farnesyltransferase Inhibitor 4 |
CAS Registry Number | NA |
NCIT ID | C201577 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Adagrasib + KO-2806 | Adagrasib KO-2806 | 0 | 1 |
Cabozantinib + KO-2806 | Cabozantinib KO-2806 | 0 | 1 |
KO-2806 | KO-2806 | 0 | 1 |
KO-2806 + MRTX-1133 | KO-2806 MRTX-1133 | 0 | 0 |